NEW ISSUE
State-of-the-Art on Coronary Physiology; a Mini Focus on Biostatistics; Post-TAVI Aortic Manipulation; Minimally Invasive Ventricular Reconstruction after MI
April 2, 2021
1. Cardiac Department, Hospital Universitario de La Princesa, IIS-IP, Universidad Autónoma de Madrid, Madrid, Spain; 2. Clinical and Experimental Interventional Cardiology, University of Saarland, Homburg/Saar, Germany
Treatment of patients with in-stent restenosis (ISR) remains a technical challenge and continues to represent a major clinical problem1. Although bare metal stents (BMS) are still widely used they suffer from a relatively high restenosis rate, especially in complex clinical and anatomic scenarios1,2. Drug-eluting stents (DES) have drastically reduced the appearance of severe neointimal proliferation and the clinical need for repeat revascularisation. However, some patients treated with DES still develop ISR1,2. Timing, morphological patterns, underlying substrate and response to treatment differ slightly in patients with DES-ISR and those with BMS-ISR1. Indeed, DES-ISR may present relatively late after the initial procedure, ...
Sign in to read and download the full article
Forgot your password?No account yet? Sign up for free!
Create my pcr account Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com
Read next article
The EAPCI welcomes the new WOMEN initiative